A case of acquired hemophilia A in an elderly female

ABSTRACT Acquired Hemophilia A (AHA) is a bleeding diathesis related to the development of factor VIII inhibitor, which can frequently go undetected. It commonly manifests as spontaneous mucosal bleeds without any known history of a bleeding disorder, but has the potential to cause life threatening bleeding especially in elderly patients with underlying comorbidities. Here we describe a case of AHA in a 78 year old female presenting with spontaneous mucocutaneous bleeding as tongue hematoma and recurrent gastrointestinal (GI) bleeding. Underlying etiology remained unclear in this case. While she did not require any reversal agents to control bleeding, the patient received steroids and rituximab as inhibitor eradication therapy.

• Publication year

  2018

• Venue

  Journal of Community Hospital Internal Medicine Perspectives

• Publication date

  2018-07-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/20009666.2018.1487246PMID 30181835PMCID 6116292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy.

  2013cited by this paper
• How I manage patients with acquired haemophilia A

  2013cited by this paper
• Factor Eight Inhibitor Bypassing Activity

  2012cited by this paper
• Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?

  2012cited by this paper
• Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

  2012cited by this paper
• Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

  2012cited by this paper
• Acquired hemophilia in malignancy.

  2012cited by this paper
• Hemophilia A induced by ipilimumab.

  2011cited by this paper
• International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

  2009cited by this paper
• Rituximab in the treatment of adult acquired hemophilia A: a systematic review.

  2007cited by this paper
• Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal

  2007cited by this paper
• Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

  2007cited by this paper
• Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.

  2005cited by this paper
• Acquired hemophilia A: A concise review

  2005cited by this paper
• Treatment of acquired haemophilia with factor eight inhibitor bypassing activity

  2004cited by this paper
• An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.

  2003cited by this paper
• New protocol for immune tolerance induction in acquired hemophilia.

  2000cited by this paper
• The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre Study

  1997cited by this paper
• Low response to high‐dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor

  1996cited by this paper
• A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin.

  1995cited by this paper
• A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII

  1981cited by this paper
• Detection of factor VIII inhibitors with the partial thromboplastin time.

  1977cited by this paper

• Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States

  2023cites this paper
• Treatment of a compartment syndrome in the leg in an elderly patient with acquired hemophilia type A: A case report

  2023cites this paper
• Acquired hemophilia in patients on oral anticoagulant therapy: Case report

  2022cites this paper
• Unexplained hemorrhagic syndrome? Consider acquired hemophilia A or B.

  2021cites this paper
• Acquired Hemophilia A: A Potentially Fatal Bleeding Disorder

  2020cites this paper
• Acquired Hemophilia A: A Rare but Potentially Fatal Bleeding Disorder

  2019influential citation